Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Investigating multi-modal signatures of clinical outcome to immunotherapy in renal cell carcinoma Sachet Shukla Dana-Farber Cancer Institute PLCO Oct 22, 2020 PLCO-679
Statistical methods to identify the “causal SNP” from among SNPs in high LD with an index SNP Mitchell Gail National Cancer Institute PLCO Oct 22, 2020 PLCO-678
Predicting time to castration resistance in hormone sensitive prostate cancer Ari Robinson The Institute for Medical BioMathematics (IMBM) PLCO Oct 22, 2020 PLCO-677
Assessing the Risk and Cost of the Digital Rectal Exam: Is It Time to Abandon the DRE? Sanoj Punnen University of Miami Miller School of Medicine PLCO Oct 8, 2020 PLCO-671
Biological bases of lung cancer risk disparities for African American male smokers Chengguo Xing University of Florida PLCO Oct 8, 2020 PLCO-673
Clonal mosaic chromosomal alterations and mortality in PLCO Mitchell Machiela National Cancer Institute PLCO Oct 8, 2020 PLCO-674
The impact of diabetes on lung cancer incidence and prognosis according to histologic subtype Amanda Leiter Icahn School of Medicine at Mount Sinai PLCO Sep 22, 2020 PLCO-668
Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer Mark Purdue DCEG, NCI PLCO Sep 18, 2020 2020-0003
Cancer survival analysis using semisupervised learning method based on Cox and AFT models with L1/2 regularization Vaishali Gadhiya Laurentian University PLCO Sep 16, 2020 PLCO-666
Characteristics associated with weightlifting, cancer risk and associated mortality Jessica Gorzelitz NCI / DCEG / MEB PLCO Sep 10, 2020 PLCO-665
DNA methylation and breast cancer risk Jirong Long Vanderbilt University Medical Center PLCO Sep 1, 2020 PLCO-663
Consumption of sugar, sugar-sweetened beverages and liver cancer Katherine McGlynn National Cancer Institute PLCO Sep 1, 2020 PLCO-664
Estimate heritability of survival for selected diseases Jianxin Shi National Cancer Institute PLCO Aug 20, 2020 PLCO-661
Risk Factors for Lung Cancer in Never Smokers: Insight from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset Farouk Dako University of Pennsylvania PLCO Aug 18, 2020 PLCO-660
Associations between Dietary Plant Seed Consumption and Overall and Cause-Specific Mortality Risk Jiaqi Huang National Cancer Institute PLCO Aug 5, 2020 PLCO-653
Germline genetics of prostate cancer, PSA, and BPH using the expanded PLCO GWAS Sonja Berndt National Cancer Institute PLCO Aug 5, 2020 PLCO-659
Deep Learning for Chest X-Ray Radiological Findings Related to Covid-19 Bambang Trilaksono PT Riset Kecerdasan Buatan PLCO Jul 24, 2020 PLCOI-656
Using Machine Learning for the Early Diagnosis of Pancreatic Cancer Carol Hersh Great Neck South High School PLCO Jul 21, 2020 PLCO-651
BRCA and HNPCC Carriers in PLCO Paul Pinsky NCI PLCO Jul 17, 2020 PLCO-644
Impact of Prostatitis and Benign Prostate Hyperplasia (BPH) on risk factors for Prostate Cancer Andrew Marks Claremont Graduate University PLCO Jul 17, 2020 PLCO-641